Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Immunomedics Inc (NASDAQ:IMMU)

6.97
BATS BZX Real-Time Price
As of 12:19pm ET
 +0.02 / +0.29%
Today’s Change
1.95
Today|||52-Week Range
7.15
+89.92%
Year-to-Date
Immunomedics, Mylan Lead Biotech Movers
Mar 24 / TheStreet.com - Paid Partner Content
 

Today’s Trading

Previous close6.95
Today’s open7.00
Day’s range6.92 - 7.15
Volume112,841
Average volume (3 months)3,226,587
Market cap$737.3M
Dividend yield--
Data as of 12:19pm ET, 03/28/2017

Growth & Valuation

Earnings growth (last year)-21.57%
Earnings growth (this year)+2.42%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)-42.81%
P/E ratioNM
Price/Sales68.00
Price/Book--

Competitors

 Today’s
change
Today’s
% change
QDELQuidel Corp-0.39-1.76%
--Quidel Corp-0.02-0.10%
ALRPRBAlere Inc+4.00+1.23%
VIVOMeridian Bioscience ...-0.03-0.19%
Data as of 12:18pm ET, 03/28/2017

Financials

Next reporting dateMay 10, 2017
EPS forecast (this quarter)-$0.13
Annual revenue (last year)$3.2M
Annual profit (last year)-$59.0M
Net profit margin-1,825.93%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Chief Scientific &
Patent Officer
David M. Goldenberg
President, Chief Executive Officer &
Director
Cynthia L. Sullivan
Corporate headquarters
Morris Plains, New Jersey

Forecasts


Search for Jobs